ЭНДЕЛЛЬ Ян (DE),БОКСХАММЕР Райнер (DE),ВИНДЕРЛИХ Марк (DE)
申请号：
RU2017143166
公开号：
RU2017143166A
申请日:
2016.05.25
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a Bruton's tyrosine kinase (BTK) inhibitor for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.
